Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VitC-AF: IV Vitamin C in AF Ablation
NCT03148236Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Vitamin C with Placebo (2 arms). Primary endpoints: Change in Creatinine Levels at 30 days, Change in Plasma Levels of Ascorbic Acid at 30 days and 3 more. Started Sep 2017; status: completed.
02
Drugs
ascorbic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03148236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03148236.